NEW YORK (GenomeWeb) – Through a molecular analysis, researchers from the Cancer Genome Atlas Research Network have found that three-quarters of primary prostate cancers fall into one of seven subtypes.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.
This online seminar will provide an overview of the use of liquid biopsies for cancer recurrence monitoring with a particular focus on colorectal cancer.
This webinar will provide an overview of an RNA-seq protocol that has been optimized to study small RNA species such as microRNAs.
This webinar will discuss a target enrichment workflow for high-confidence detection of variants.
This webinar will discuss RNA sequencing as an alternative to immunohistochemistry (IHC) in selecting patients for cancer immunotherapy.